NTQ5082 not checked
Nanjing Chia-tai Tianqing Pharmaceutical
FollowEvery change as it happens, and a Monday email
Trials
4 active
6 in total
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Paroxysmal Nocturnal Hemoglobinuria (3 trials), Primary IgA Nephropathy
- Main trialPhase 3
- “NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, randomized, open-label, active-controlled Phase III clinical trial designed to evaluate the efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria.”In the company’s words, NCT07177859 on ClinicalTrials.gov
Other drugs for Paroxysmal Nocturnal Hemoglobinuria
- MY008211AWuhan Createrna Science and Technology Co., Ltd · Phase 3
- CrovalimabRoche · Phase 3
- DanicopanAlexion Pharmaceuticals, Inc. · Phase 3
- VSA012Bisirna Therapeutics (Suzhou) Co., Ltd. · Phase 3
- IptacopanNovartis Pharmaceuticals · Phase 3
- FXS6837Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Phase 3
Coming up2
- NovPhase 3 trial completes · ClinicalTrials.gov
- Jun 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | Nov 2026 | A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients | |
| Phase 3Not yet recruiting | Jun 2028 | A Long-term Efficacy and Safety of NTQ5082 Capsules | |
| Phase 2Active, not recruiting | 8 Jul 2025 | A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients | |
| Phase 2Not yet recruiting | Sep 2026 | Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy | |
| Phase 1Unknown | Dec 2024 | Effect of Food of NTQ5082 in Healthy Subjects | |
| Phase 1Unknown | Dec 2024 | A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026